Skip to main content
. 2022 Aug 31;22:326. doi: 10.1186/s12883-022-02847-3

Table 3.

Multivariate analysis of dynamic NLR using different models

NLR Mortality at 1 mo
Crude modela Adjusted model Ib Adjusted model IIc
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
At admission 1.08 (1.00, 1.17) 0.058 1.08 (0.99, 1.17) 0.087 1.00 (0.86, 1.16) 0.971
Immediately after EVT 1.05 (0.99, 1.11) 0.111 1.04 (0.98, 1.10) 0.219 1.05 (0.94, 1.17) 0.422
Within 12–24 h after EVT 1.14 (1.07, 1.20) < 0.001 1.14 (1.07, 1.22) < 0.001 1.18 (1.04, 1.33) 0.008
Within 24–48 h after EVT 1.13 (1.05, 1.22) 0.002 1.12 (1.03, 1.21) 0.005 1.16 (1.01, 1.35) 0.044
Within 48–72 h after EVT 1.22 (1.12, 1.33) 0.001 1.23 (1.12, 1.35) < 0.001 1.23 (1.03, 1.47) 0.021

NLR Neutrophil-to-lymphocyte ratio, OR Odds ratio, CI Confidence interval, EVT Endovascular treatment

aCrude model: not adjusted for other covariates

bAdjusted model I: adjusted for sex and age

cAdjusted model II: sex; age; history of diabetes; history of chronic kidney disease; baseline NIHSS score; bridging intravenous thrombolysis; cardioembolic stroke; internal carotid artery occlusion; favorable collateral circulation; pneumonia during hospitalization; symptomatic intracerebral hemorrhage during hospitalization; sepsis during hospitalization; anticoagulation during hospitalization; use of invasive mechanical ventilation during hospitalization; use of vasopressors during hospitalization